Oxaliplatin
- Product NDC
- 70860-201
- 11-digit product format
- 708600201
- Labeler code
- 70860
- Product ID
- 70860-201_6819e9e1-e1b2-4367-88c0-6e0a8253bd85
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxaliplatin
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA207325
- Marketing category
- ANDA
- Marketing start
- 2017-03-15
- Marketing end
- 0000-00-00
- Substance
- OXALIPLATIN
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Platinum-based Drug [EPC],Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-201-10 | 70860020110 | 1 VIAL in 1 CARTON (70860-201-10) > 10 mL in 1 VIAL | 1 vial | 2017-03-15 | 0000-00-00 | No | No | Current |
| 70860-201-20 | 70860020120 | 1 VIAL in 1 CARTON (70860-201-20) > 20 mL in 1 VIAL | 1 vial | 2017-03-15 | 0000-00-00 | No | No | Current |